← k3vl4r
Log inGet started →

ORGO (Organogenesis Holdings Inc) Price Forecast

AI-generated price forecast for Organogenesis Holdings Inc (ORGO) across 1-hour, 4-hour, daily and weekly horizons — updated continuously, with a public accuracy track record.

The desk streams live daily· see the schedule →

As of November 2026: K3vl4r's calibrated AI forecast currently reads ORGO as 1/1 bearish across its horizons (0 of 1 timeframes pointing up), with a last price of 0.7600. See our public, auditable track record →

📈 Daily Top Picks beating the S&P 500 since launch→✓ Public, verifiable track record Live system status💎 Get the full AI report · pay with XRP

Last price

0.7600

AI outlook

1/1 bearish

Timeframes up

0 / 1

Share𝕏PostTelegram

ORGO forecast by horizon

HorizonDirectionCalibrated move (end of horizon)
1-hour——
4-hour——
Daily~4 weeks out▼ Down-75.31%
WeeklyNot enough track record yet—

Calibrated: each horizon's forecast is weighted by how often the model has called ORGO's direction correctly over the last 30 days, and reversed where it has been wrong more often than right. A horizon votes only once it has enough resolved forecasts.

Latest ORGO news

From the market-news feed the forecasts are read against.

  • Organogenesis (NASDAQ:ORGO) Shares Down 3.6% – What’s Next? · ldr:tickerreport.com · Oct 24
  • Organogenesis Announces Publication of Peer-Reviewed PREPARE Trial Results Demonstrating Clinical Benefit of PuraPly®AM for Hard-to-Heal Diabetic Foot Ulcers · Yahoo · Oct 12
  • Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2026 Financial Results on November 5, 2026 · Yahoo · Oct 12
  • Organogenesis Holdings Announces Publication Of Results From PREPARE, Multicenter, RCT Evaluating PuraPlyAM Plus SoC Compared To SoC Alone In Hard-To-Heal Diabetic Foot Ulcers · Benzinga · Oct 12

🔒

See the full ORGO forecast

Interactive forecast chart, price targets, and Monte-Carlo confidence bands — plus the daily AI Top Picks book. Free to start, no card required.

Create a free account →

Already have one? Log in

ORGO forecast — frequently asked

Will ORGO go up?

K3vl4r's calibrated AI forecast currently reads ORGO as 1/1 bearish — 0 of 1 forecast horizons point up, so the overall read is leaning to the downside. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

What is the ORGO price prediction for 2026?

K3vl4r's model projects ORGO toward $0.1867 over the next ~4 weeks, a -75.3% move from $0.7565. Projections update continuously as new data arrives and are inherently uncertain. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

Part of Healthcare forecasts — browse the full sector.

More AI forecasts

GANXLXRXMISTOCGNLABACADCRDFBGMZLABHUMAGMABMGTXMRVIWRBY

Will ORGO reach…?

Will ORGO reach $1.00?Will ORGO reach $2.00?Will ORGO reach $3.00?Will ORGO reach $5.00?

Or see the full ORGO price prediction (2027–2040), or the forecast for today, tomorrow and this week.

Compare ORGO

ORGO vs GANXORGO vs LXRXORGO vs MISTORGO vs OCGNORGO vs LABORGO vs ACAD

Curious how this is generated? Read how K3vl4r forecasts — the model, the confidence bands, and what we deliberately do not claim.

K3vl4r publishes a public, auditable track record of its Daily Top Picks — see the live results.

Forecasts are model-generated estimates for informational purposes only and are not financial advice. Markets are risky; past accuracy does not guarantee future results. See our Risk Disclosure.

StreamWatch on Kick·Watch on YouTube
k3vl4rTop PicksTrack recordChart indicatorsToday's outlookStream scheduleBiggest moversMarket heatmapForecasts by sectorAI reportsMarket videosCompareMethodologyBest AI toolsAboutFAQ◈ KVLHow KVL worksTokenomicsPricingX (Twitter)YouTube — daily showsTikTokTwitch — live forecastingDiscord community

Join the community on Discord and catch the desk stream live on Kick or YouTube. Create a free account →

Forecasts are AI-generated; written analysis is AI-assisted and human-reviewed. Informational only, not financial advice. See Terms, Risk Disclosure, Privacy · Methodology · Status.